Non-human primates as a model for understanding the mechanism of action of toll-like receptor-based vaccine adjuvants

Coffman, 2010, Vaccine adjuvants: putting innate immunity to work, Immunity, 33, 492, 10.1016/j.immuni.2010.10.002

Garçon, 2011, Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems, Expert Rev Vaccines, 10, 471, 10.1586/erv.11.29

Didierlaurent, 2017, Adjuvant system AS01: helping to overcome the challenges of modern vaccines, Expert Rev Vaccines, 16, 55, 10.1080/14760584.2016.1213632

Santini-Oliveira, 2016, Schistosomiasis vaccine candidate Sm14/GLA-SE: phase 1 safety and immunogenicity clinical trial in healthy, male adults, Vaccine, 34, 586, 10.1016/j.vaccine.2015.10.027

Treanor, 2013, Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant, Vaccine, 31, 5760, 10.1016/j.vaccine.2013.08.064

Okada, 2015, Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC, Clin Cancer Res, 21, 286, 10.1158/1078-0432.CCR-14-1790

Sabado, 2015, Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma, Cancer Immunol Res, 3, 278, 10.1158/2326-6066.CIR-14-0202

Karbach, 2011, Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients, Clin Cancer Res, 17, 861, 10.1158/1078-0432.CCR-10-1811

Shedlock, 2009, Monkeying around with HIV vaccines: using rhesus macaques to define “gatekeepers” for clinical trials, Nat Rev Immunol, 9, 717, 10.1038/nri2636

Meyer, 2015, Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses, J Clin Investig, 125, 3241, 10.1172/JCI81532

Stanley, 2014, Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge, Nat Med, 20, 1126, 10.1038/nm.3702

Abbink, 2016, Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys, Science, 353, 1129, 10.1126/science.aah6157

Ishizuka, 2016, Protection against malaria at 1 year and immune correlates following PfSPZ vaccination, Nat Med, 22, 614, 10.1038/nm.4110

Smed-Sörensen, 2013, Targeting dendritic cells for improved HIV-1 vaccines, Adv Exp Med Biol, 762, 263, 10.1007/978-1-4614-4433-6_10

Hornung, 2002, Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides, J Immunol, 168, 4531, 10.4049/jimmunol.168.9.4531

Gururajan, 2007, Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets, PLoS ONE, 2, e863, 10.1371/journal.pone.0000863

Ketloy, 2008, Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates, Vet Immunol Immunopathol, 125, 18, 10.1016/j.vetimm.2008.05.001

Iwasaki, 2004, Toll-like receptor control of the adaptive immune responses, Nat Immunol, 5, 987, 10.1038/ni1112

Flacher, 2006, Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria, J Immunol, 177, 7959, 10.4049/jimmunol.177.11.7959

Larson, 2016, Ly6C(+) monocyte efferocytosis and cross-presentation of cell-associated antigens, Cell Death Differ, 23, 997, 10.1038/cdd.2016.24

Cunningham, 2013, Immunobiology of dendritic cells and the influence of HIV infection, Adv Exp Med Biol, 762, 1

Kastenmüller, 2014, Dendritic cell-targeted vaccines—hope or hype?, Nat Rev Immunol, 14, 705, 10.1038/nri3727

Mitsui, 2004, Differential expression and function of toll-like receptors in langerhans cells: comparison with splenic dendritic cells, J Investig Dermatol, 122, 95, 10.1046/j.0022-202X.2003.22116.x

Guilliams, 2016, Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species, Immunity, 45, 669, 10.1016/j.immuni.2016.08.015

Dutertre C-AA, 2014, TLR3-responsive, XCR1+, CD141(BDCA-3)+/CD8α+-equivalent dendritic cells uncovered in healthy and simian immunodeficiency virus-infected rhesus macaques, J Immunol, 192, 4697, 10.4049/jimmunol.1302448

Vono, 2017, Neutrophils acquire the capacity for antigen presentation to memory CD4(+) T cells in vitro and ex vivo, Blood, 129, 1991, 10.1182/blood-2016-10-744441

Kadowaki, 2001, Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens, J Exp Med, 194, 863, 10.1084/jem.194.6.863

Kwissa, 2014, Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation, Cell Host Microbe, 16, 115, 10.1016/j.chom.2014.06.001

Bekeredjian-Ding, 2005, Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN [Internet], J Immunol, 174, 4043, 10.4049/jimmunol.174.7.4043

Querec, 2009, Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans, Nat Immunol, 10, 116, 10.1038/ni.1688

Li, 2014, Molecular signatures of antibody responses derived from a systems biology study of five human vaccines, Nat Immunol, 15, 195, 10.1038/ni.2789

Kwissa, 2012, adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates, Blood, 119, 2044, 10.1182/blood-2011-10-388579

Caskey, 2011, Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans, J Exp Med, 208, 2357, 10.1084/jem.20111171

Kasturi, 2017, Adjuvanting a simian immunodeficiency virus vaccine with toll-like receptor ligands encapsulated in nanoparticles induces persistent antibody responses and enhanced protection in TRIM5α restrictive macaques, J Virol, 91, 10.1128/JVI.01844-16

Thompson, 2015, Human anti-CD40 antibody and poly IC:LC adjuvant combination induces potent T cell responses in the lung of nonhuman primates, J Immunol, 195, 1015, 10.4049/jimmunol.1500078

Bolton, 2017, Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques, Vaccine, 35, 639, 10.1016/j.vaccine.2016.12.008

Liang, 2017, Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake, Sci Transl Med, 9, 10.1126/scitranslmed.aal2094

Wu, 2014, Rational design of small molecules as vaccine adjuvants, Sci Transl Med, 6, 263ra160, 10.1126/scitranslmed.3009980

Mothé, 2013, Peptide-binding motifs associated with MHC molecules common in Chinese rhesus macaques are analogous to those of human HLA supertypes and include HLA-B27-like alleles, Immunogenetics, 65, 371, 10.1007/s00251-013-0686-9

Wiseman, 2013, Haplessly hoping: macaque major histocompatibility complex made easy, Ilar J, 54, 196, 10.1093/ilar/ilt036

Mothé, 2015, The TB-specific CD4+ T cell immune repertoire in both cynomolgus and rhesus macaques largely overlap with humans, Tuberculosis, 95, 722, 10.1016/j.tube.2015.07.005

Beura, 2016, Normalizing the environment recapitulates adult human immune traits in laboratory mice, Nature, 532, 512, 10.1038/nature17655

Herath, 2016, Strain-dependent and distinctive T-cell responses to HIV antigens following immunisation of mice with differing chimpanzee adenovirus vaccine vectors, Vaccine, 34, 4378, 10.1016/j.vaccine.2016.07.028

Reese, 2016, Sequential infection with common pathogens promotes human-like immune gene expression and altered vaccine response, Cell Host Microbe, 19, 713, 10.1016/j.chom.2016.04.003

Seder, 2008, T-cell quality in memory and protection: implications for vaccine design, Nat Rev Immunol, 8, 247, 10.1038/nri2274

Lorin, 2015, Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques, PLOS ONE, 10, e0122835, 10.1371/journal.pone.0122835

Patton, 2015, Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques, Vaccine, 33, 4472, 10.1016/j.vaccine.2015.07.025

Borducchi, 2016, Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys, Nature, 540, 284, 10.1038/nature20583

Silveira, 2015, Vaccine-induced plasmablast responses in rhesus macaques: phenotypic characterization and a source for generating antigen-specific monoclonal antibodies, J Immunol Methods, 416, 69, 10.1016/j.jim.2014.11.003

Martinez, 2015, Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation, Sci Rep, 5, 8925, 10.1038/srep08925

Park, 2013, Polyinosinic-polycytidylic acid is the most effective TLR adjuvant for SIV Gag protein-induced T cell responses in nonhuman primates, J Immunol, 190, 4103, 10.4049/jimmunol.1202958

Wille-Reece, 2006, Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates, J Exp Med, 203, 1249, 10.1084/jem.20052433

Segura, 2015, Cross-presentation in mouse and human dendritic cells, Adv Immunol, 127, 1, 10.1016/bs.ai.2015.03.002

Mueller, 2016, Tissue-resident memory T cells: local specialists in immune defence, Nat Rev Immunol, 16, 79, 10.1038/nri.2015.3

Pichyangkul, 2015, Tissue distribution of Memory T and B cells in rhesus monkeys following influenza A infection, J Immunol, 195, 4378, 10.4049/jimmunol.1501702

Veazey, 2015, Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques, Hum Vaccines Immunother, 11, 2913, 10.1080/21645515.2015.1070998

Moody, 2014, Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques, J Virol, 88, 3329, 10.1128/JVI.03309-13

Fernandez, 2015, An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques, Am J Trop Med Hyg, 92, 698, 10.4269/ajtmh.14-0268

Barouch, 2015, Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys, Science, 349, 320, 10.1126/science.aab3886

Francica, 2015, Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunization, Nat Commun, 6, 6565, 10.1038/ncomms7565

Corcoran, 2016, Production of individualized V gene databases reveals high levels of immunoglobulin genetic diversity, Nat Commun, 7, 13642, 10.1038/ncomms13642